Is AVTE or DGRO a better dividend investment in 2026?

AVTE currently yields 74.63% with a 5% 5-year dividend growth rate. DGRO yields 2.13% with 9.5% growth. The better choice depends on your goal: AVTE offers higher current income.

What is the dividend yield difference between AVTE and DGRO?

AVTE has a forward dividend yield of 74.63% ($2.00/share annually). DGRO yields 2.13% ($1.47/share annually). The yield gap is 72.50 percentage points.

Home › Compare › AVTE vs DGRO

AVTE vs DGRO: Dividend Comparison 2026

AVTE yields 74.63% · DGRO yields 2.13%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 AVTE wins by $1.27M in total portfolio value

INVESTMENT

TIME HORIZON10 years

AVTE

● Live price

74.63%

Share price

$2.68

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1.30M

Annual income

$358,033.82

Full AVTE calculator →

DGRO

iShares Core Dividend Growth ETF

● Live price

2.13%

Share price

$68.98

Annual div

$1.47

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$31.6K

Annual income

$239.96

Full DGRO calculator →

Portfolio growth — AVTE vs DGRO

📍 AVTE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	AVTE	DGRO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, AVTE + DGRO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

AVTE pays

DGRO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AVTE

Annual income on $10K today (after 15% tax)

$6,343.28/yr

After 10yr DRIP, annual income (after tax)

$304,328.75/yr

DGRO

Annual income on $10K today (after 15% tax)

$181.24/yr

After 10yr DRIP, annual income (after tax)

$203.97/yr

At 15% tax rate, AVTE beats the other by $304,124.78/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AVTE + DGRO for your $10,000?

AVTE: 50%DGRO: 50%

100% DGRO50/50100% AVTE

Portfolio after 10yr

$666.7K

Annual income

$179,136.89/yr

Blended yield

26.87%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on AVTE right now

AVTE

Analyst Ratings

Buy

Hold

Consensus: Hold

Price Target

$13.00

+385.1% upside vs current

Range: $2.00 — $35.00

Altman Z

2.1

Piotroski

2/9

DGRO

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AVTE buys

DGRO buys

No recent congressional trades found for AVTE or DGRO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricAVTEDGRO

Forward yield	74.63% ✓	2.13%
Annual dividend / share	$2.00 ✓	$1.47
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$1.30M	$31.6K ✓
Annual income after 10y	$358,033.82 ✓	$239.96
Total dividends collected	$1.12M	$2.3K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: AVTE vs DGRO ($10,000, DRIP)

Year	AVTE Portfolio	AVTE Income/yr	DGRO Portfolio	DGRO Income/yr	Gap
1← crossover	$18,163	$7,462.69	$11,293	$213.22	+$6.9K → AVTE
2	$32,102	$12,667.52	$12,730	$217.32	+$19.4K → AVTE
3	$55,273	$20,924.46	$14,326	$221.10	+$40.9K → AVTE
4	$92,813	$33,671.17	$16,098	$224.56	+$76.7K → AVTE
5	$152,151	$52,841.00	$18,064	$227.74	+$134.1K → AVTE
6	$243,759	$80,956.60	$20,246	$230.65	+$223.5K → AVTE
7	$382,036	$121,213.91	$22,666	$233.30	+$359.4K → AVTE
8	$586,325	$177,546.69	$25,349	$235.73	+$561.0K → AVTE
9	$882,029	$254,661.46	$28,325	$237.94	+$853.7K → AVTE
10	$1,301,805	$358,033.82	$31,624	$239.96	+$1.27M → AVTE

AVTE vs DGRO: Complete Analysis 2026

AVTE — Stock

Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. Aerovate Therapeutics, Inc. was incorporated in 2018 and is headquartered in Waltham, Massachusetts.

Full AVTE Calculator →

DGRO — ETF

The iShares Core Dividend Growth ETF seeks to track the investment results of an index composed of U.S. equities with a history of consistently growing dividends.

Full DGRO Calculator →

📬

Get this AVTE vs DGRO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AVTE vs SCHD AVTE vs JEPI AVTE vs O AVTE vs KO AVTE vs MAIN AVTE vs VIG AVTE vs NOBL AVTE vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.